Gardasil demand in China sinks, and Merck expects the same next quarter

Merck said sales of its HPV vaccine Gardasil — its second-largest product — dipped again in the third quarter, citing reduced demand in China, where the shot is only approved for females. Gardasil’s sales were down 11 ...